Pembrolizumab-Induced Simultaneous and Refractory Systemic Capillary Leak and Cytokine Release Syndromes: A Case Report

Systemic Capillary Leak Syndrome (SCLS) and Cytokine Release Syndrome (CRS) have both been described as rare but severe adverse reactions induced by Programmed cell death protein 1 (PD-1) inhibitors such as pembrolizumab. We report the case of a 40-year-old woman undergoing treatment with pembrolizu...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Eugénie Roberge-Maltais, Eric Lévesque, Vincent Castonguay, Nicolas Marcoux, Louis-Philippe Grenier, Martin Veilleux
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2025-08-01
Ráidu:	Current Oncology
Fáttát:	capillary leak syndrome cytokine release syndrome immune checkpoint inhibitors PD-1 inhibitors ruxolitinib axitinib
Liŋkkat:	https://www.mdpi.com/1718-7729/32/8/469
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!